Regulatory Updates
🇪🇺 EMA Page 9EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 97–108 of 171 articles
Critical Medicines Act: Council and Parliament Reach Provisional Deal
PRAC Meeting Highlights: Regulatory Updates from May 2026
Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA®
EU Panel Endorses Expanded Applications for Cancer Medications
Critical Medicines Act Targets Europe's Medicines Shortages
Imfinzi Approved for Unique Bladder Cancer Combo: A Game Changer
Hansa Licenses Idefirix to SERB for $133M: Implications for Investors
EMA Management Board Meeting Highlights: March 2026 on Clinical Trials
Camizestrant Recommended for Approval in the EU for Advanced ER-Positive Breast Cancer
Tarsier Pharma IPO: NYSE Listings Expand with New Opportunities
European Critical Medicines Act: Market Analysis and Implications
AI Accelerates Novo Nordisk's Parkinson’s Cell Therapy